TCL Archive Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival November 29, 2013
TCL Archive In Brief: Yarbro To Leave As NCI Centers Chief to Head Missouri Cancer Program; Replaced By Cantril May 30, 1975
TCL Archive After Congressional Inquiry, NCI Posts Ambiguous Statement On Abortion And Breast Cancer Risk December 13, 2002